Tanuja Narayansamy Gengiah

11PUBLICATIONS
27CO-AUTHORS
Psychosocial aspects of childbirth and perinatal mental healthNanotoxicology, health and safetyInnate immunityPharmaceutical delivery technologiesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 17, 2026
Written on the Skin: Participants' Perspectives on Scarring, Discolouration and Implant Site Reactions Experienced During a Phase I Clinical Trial for a Subdermal HIV Prevention Implant in KwaZulu-Natal, South Africa.

|Apr 16, 2026
Impact of Tenofovir Alafenamide Sub-Dermal Implant Insertion Site Scarring on Acceptability and HIV Prevention Preferences: A Prospective Cohort Study in Durban, South Africa.

|Mar 06, 2026
"There is nobody who wouldn't like to": understanding the motivations behind women's participation in a Phase I clinical trial for a subdermal HIV prevention implant in KwaZulu-Natal, South Africa.

Emma Durden, Eliza Govender, Aphiwe Dlokweni

|Nov 07, 2025
Willingness to switch to injectable cabotegravir among oral PrEP users in Durban, South Africa.

Tanuja N Gengiah, Vaishnavi Naidoo, Nothile Dlamini

|Jun 03, 2025
Population pharmacokinetics of weight-based compared with fixed dosing of CAP256V2LS, a broadly neutralizing antibody for HIV prevention in women.

Sharana Mahomed, Martin Beliveau, Roberto Heredia-Ortiz

|Feb 21, 2025
Acceptability of an annual tenofovir alafenamide implant for HIV prevention in South African women: findings from the CAPRISA 018 Phase I clinical trial.

Tanuja N Gengiah, Craig J Heck, Lara Lewis

Pageof 2

Frequent Collaborators

4 joint publications

Leila E Mansoor

3 joint publications

Salim S Abdool Karim

3 joint publications

Quarraisha Abdool Karim

2 joint publications

Eliza Govender